Only four genes, namely, Col1a2, Efemp2, Fbln5, and Thbs2 were found consistently across six published transcriptomic studies on NASH(Pantano et al., 2021). This evidence concerns the gene FBLN5 and metabolic dysfunction-associated steatohepatitis.